7-Hydroxycarbostyril
CAS No. 70500-72-0
7-Hydroxycarbostyril ( 3,4-Dihydro-7-hydroxycarbostyril )
产品货号. M27524 CAS No. 70500-72-0
7-羟基喹诺酮(3,4-二氢-7-羟基喹诺酮)是一种医药中间体。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥413 | 有现货 |
|
| 25MG | ¥632 | 有现货 |
|
| 50MG | ¥956 | 有现货 |
|
| 100MG | ¥1426 | 有现货 |
|
| 200MG | ¥2147 | 有现货 |
|
| 500MG | ¥3216 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称7-Hydroxycarbostyril
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述7-羟基喹诺酮(3,4-二氢-7-羟基喹诺酮)是一种医药中间体。
-
产品描述7-Hydroxycarbostyril (3,4-Dihydro-7-hydroxycarbostyril) is a kind of pharmaceutical intermediate.(In Vitro):?VPC-80051 as the first small molecule inhibitor of hnRNP A1 splicing activity discovered to date by using a computer-aided drug discovery approach. The inhibitor was developed to target the RNA-binding domain (RBD) of hnRNP A1. Further experimental evaluation demonstrated that VPC-80051 interacts directly with hnRNP A1 RBD and reduces AR-V7 messenger levels in 22Rv1 CRPC cell line. This study lays the groundwork for future structure-based development of more potent and selective small molecule inhibitors of hnRNP A1?RNA interactions aimed at altering the production of cancer-specific alternative splice isoforms.
-
体外实验——
-
体内实验——
-
同义词3,4-Dihydro-7-hydroxycarbostyril
-
通路Others
-
靶点Other Targets
-
受体TRPA1
-
研究领域——
-
适应症——
化学信息
-
CAS Number70500-72-0
-
分子量161.16
-
分子式C9H7NO2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOc1ccc2ccc(O)nc2c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Takaya J, et al. A Potent and Site-Selective Agonist of TRPA1. J Am Chem Soc. 2015 Dec 23;137(50):15859-64.
产品手册
关联产品
-
HEPES Sodium
HEPES sodium 是一种非挥发的两性离子化学缓冲剂,广泛应用于细胞培养。HEPES sodium 在 pH 值为 6.8 至 8.2 时为有效的缓冲液。HEPES sodium 也是溶酶体生物发生的有效诱导剂。
-
Decarboxy Moxifloxac...
脱羧莫西沙星是莫西沙星的脱羧化合物。
-
NLRP3/AIM2-IN-2
NLRP3/AIM2-IN-2 (compound 8) 是一种对 NLRP3 和 AIM2 炎症小体依赖性细胞焦亡具有不同物种特异性作用的新型强效抑制剂,其IC50值为 0.2392 ±0.0233μM。
021-51111890
购物车()
sales@molnova.cn

